文章基本信息

标题：CURRENT SCENARIO OF THERAPEUTICS FOR EBOLA VIRUS DISEASE
本地全文：下载
作者：ML Arvinda Swamy ; Madhavan P.N. Nair ; Shailendra K. Saxena 等
期刊名称：American Journal of Infectious Diseases
印刷版ISSN：1553-6203
出版年度：2014
卷号：10
期号：3
页码：100-104
DOI：10.3844/ajidsp.2014.100.104
出版社：Science Publications
摘要：Currently various countries in Africa, including Liberia, Sierra Leone, Guinea, Nigeria, are facing disaster due to Ebola Virus Disease (EVD), which is primarily caused by Ebola virus. 2014 outbreak of Ebola associated viral haemorrhagic fever has 55-60% fatality rate. The incubation period of Ebola is below 21 days; once the appearance of symptoms starts the person will be infective. As there is no specific vaccine, antiviral or drugs for treating Ebola resulting in large number of deaths. Most of the recent outbreaks occurred in remote areas of West Africa. Poverty, lack of awareness, access to health centres, human habitats taking its toll in spreading the disease in large scale. Few nucleotide analogues, protease inhibitors, receptor binding, monoclonal antibodies and anticoagulant therapies are exhibiting promising role in inhibiting the Ebola virus in various ( in vitro and in vivo ) models.